Labeled for this condition
Medicines for fungal infections
33 medicines have an FDA label indicated for fungal infections; 24 are listed from generic labelers and 0 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for fungal infections?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Miconazole | Monistat, Oravig | 43 labelers | $0.120 per gram 2% topical cream | No | No current entry | 1 |
| Tolnaftate | none listed | none listed | $0.119 per gram 1% cream | No | No current entry | 0 |
| Clotrimazole | Cvs, Sunmark, Clotic | 24 labelers | $0.133 per gram 1% topical cream | No | No current entry | 0 |
| Fluconazole | Diflucan | 41 labelers | $0.380 per tablet 200 mg tablet | No | No current entry | 18 |
| Undecylenic acid | none listed | none listed | n/a | No | No current entry | 0 |
| Nystatin | Nystop, Klayesta, Mycostatin | 40 labelers | $0.175 per gram 100,000 unit/g cream | No | No current entry | 18 |
| Ketoconazole | Nizoral, Ketodan | 30 labelers | $0.249 per gram 2% cream | No | No current entry | 3 |
| Terbinafine | Lamisil | 39 labelers | $0.143 per tablet 250 mg tablet | No | No current entry | 0 |
| Voriconazole | Vfend | 31 labelers | $1.88 per tablet 200 mg tablet | No | A presentation being discontinued | 4 |
| Selenium sulfide | none listed | 1 labeler | $0.0141 per mL 1% shampoo | No | No current entry | 0 |
| Ciclopirox | none listed | 14 labelers | $0.169 per gram 0.77% cream | No | No current entry | 5 |
| Posaconazole | Noxafil | 27 labelers | $2.03 per tablet 100 mg tablet | No | A presentation being discontinued | 2 |
| Nystatin and triamcinolone | none listed | 18 labelers | $0.225 per gram Nystatin-triamcinolone cream | No | No current entry | 4 |
| Micafungin | none listed | 10 labelers | n/a | No | A presentation being discontinued | 4 |
| Betamethasone and clotrimazole | none listed | 16 labelers | $0.190 per gram Clotrimazole-betamethasone cream | No | No current entry | 2 |
| Griseofulvin | none listed | 10 labelers | $3.74 per tablet 250 mg tablet | No | No current entry | 0 |
| Flucytosine | Ancobon | 9 labelers | n/a | Yes | No current entry | 0 |
| Itraconazole | Tolsura, Sporanox | 11 labelers | $0.910 per capsule 100 mg capsule | Yes | A presentation being discontinued | 1 |
| Caspofungin | Cancidas | 5 labelers | n/a | No | A presentation being discontinued | 0 |
| Econazole | Ecoza | 6 labelers | $0.351 per gram 1% cream | No | No current entry | 2 |
| Terconazole | none listed | 6 labelers | $0.552 per gram 0.4% cream | No | No current entry | 1 |
| Tavaborole | none listed | 8 labelers | $3.39 per mL 5% topical solution | No | No current entry | 2 |
| Amphotericin b | none listed | 5 labelers | n/a | No | No current entry | 1 |
| Naftifine | none listed | 1 labeler | $2.00 per gram 2% cream | No | No current entry | 1 |
| Sulconazole | Exelderm | none listed | n/a | No | A presentation being discontinued | 0 |
| Anidulafungin | Eraxis | none listed | n/a | No | No current entry | 0 |
| Oxiconazole | Oxistat | 1 labeler | $3.92 per gram 1% cream | No | No current entry | 0 |
| Luliconazole | Luzu | none listed | n/a | No | No current entry | 0 |
| Miconazole and petrolatum and zinc oxide | Vusion | none listed | $9.12 per gram 0.25-15% | No | No current entry | 0 |
| Natamycin | Natacyn | none listed | n/a | No | No current entry | 0 |
| Sertaconazole | Ertaczo | none listed | n/a | No | No current entry | 0 |
| Butoconazole | Gynazole | 1 labeler | $23.30 per gram 1 2% cream | No | No current entry | 1 |
| Efinaconazole | Jublia | none listed | n/a | No | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price